e-Newsletters for Patients
Columbia University Medical Center to Lead New Treatment Trial for Fatty Liver Disease
The Division of Pediatric Gastroenterology at Morgan Stanley Children's Hospital/Columbia University Medical Center is leading a new clinical trial of cysteamine bitartrate as a potential treatment of non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease.More



